<DOC>
	<DOCNO>NCT01301508</DOCNO>
	<brief_summary>The purpose study determine whether AN2898 AN2728 ointment safe effective treatment mild-to-moderate atopic dermatitis ( AD ) .</brief_summary>
	<brief_title>Efficacy Safety AN2898 AN2728 Topical Ointments Treat Mild-to-Moderate Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Clinical diagnosis atopic dermatitis clinically stable ≥1 month Total body surface area ( BSA ) atopic dermatitis involvement ≤35 % , exclude involvement face , scalp , groin Presence two ( 2 ) comparable target lesion Willing able apply study medication direct , comply study instruction , commit attend visit Females childbearing potential must use least one highly effective method birth control . Males partner childbearing potential inform participation clinical study use highly effective method birth control study . Concurrent recent use certain topical systemic medication phototherapy without sufficient washout period Active potentially recurrent dermatologic condition atopic dermatitis target lesion area may confound evaluation Significant confounding condition assess study doctor History evidence allergy require acute chronic treatment ( except seasonal allergic rhinitis ) Participated trial investigational drug device within 30 day participation research study concurrent study Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>atopic dermatitis</keyword>
</DOC>